Suppr超能文献

尼泊尔酒精使用障碍男性血清脑源性神经营养因子水平与共病抑郁及细胞因子水平的关系

Serum brain-derived neurotrophic factor levels in relation to comorbid depression and cytokine levels in Nepalese men with alcohol-use disorders.

作者信息

Neupane Sudan Prasad, Lien Lars, Ueland Thor, Mollnes Tom Eirik, Aukrust Pål, Bramness Jørgen G

机构信息

SERAF-Norwegian Centre for Addiction Research, University of Oslo, Norway.

SERAF-Norwegian Centre for Addiction Research, University of Oslo, Norway; Innlandet Hospital Trust, Hamar, Norway; Department of Public Health, Hedmark University College, Elverum, Norway.

出版信息

Alcohol. 2015 Aug;49(5):471-8. doi: 10.1016/j.alcohol.2015.01.012. Epub 2015 Mar 22.

Abstract

Neurodegenerative and inflammatory processes are involved separately in major depression (MD) and alcohol-use disorders (AUD). Little is known about the nature of this relationship in the context of comorbid AUD and depression disorders. In this study, we determined brain-derived neurotrophic factor (BDNF) serum levels in patients with AUD and tested whether BDNF levels were related to history of major depression, recent depressive symptoms, AUD severity, and TNF-α and IL-6 levels. Nepalese male AUD inpatients (N=152) abstinent from alcohol for an average of 34 days were administered structured interviews to assess depression symptoms and pattern and extent of alcohol use, and to generate research diagnoses for AUD and MD. AUD severity was assessed by scores on the Alcohol Use Disorder Identification Test. Serum BDNF and cytokines were measured using ELISA and multiplex technology, respectively. Although serum BDNF levels were unrelated to MD history, patients with recent depressive symptoms (n=42) had lower (mean±SD) BDNF serum levels compared to those without (n=110) (21.6±8.1 ng/mL vs. 26.0±9.6 ng/mL; p=0.010), and patients with higher AUD severity and binge-drinking patterns had higher mean serum BDNF levels compared to lower AUD severity and non-binging (25.9±9.7 ng/mL vs. 22.1±8.7 ng/mL; p=0.022 and 25.7±9.3 vs. 21.8±9.7 ng/mL; p=0.029, respectively). Positive correlations were present between BDNF and TNF-α (r=0.39, p<0.001) and IL-6 (r=0.2, p=0.027). In particular, TNF-α levels were predictive of BDNF levels after controlling for confounders (B=0.3 [95% CI=0.2-0.5], p<0.001). These findings show that in alcohol-using populations, peripheral BDNF levels are related to severity of AUD as well as presence of depressive symptoms. The significant associations between inflammatory and neurotrophic factors may have implications for neuroadaptive changes during recovery from AUD.

摘要

神经退行性变和炎症过程分别与重度抑郁症(MD)和酒精使用障碍(AUD)有关。对于共病酒精使用障碍和抑郁症的情况下这种关系的本质知之甚少。在本研究中,我们测定了酒精使用障碍患者的脑源性神经营养因子(BDNF)血清水平,并测试BDNF水平是否与重度抑郁症病史、近期抑郁症状、酒精使用障碍严重程度以及肿瘤坏死因子-α(TNF-α)和白细胞介素-6(IL-6)水平相关。对平均戒酒34天的尼泊尔男性酒精使用障碍住院患者(N = 152)进行结构化访谈,以评估抑郁症状以及酒精使用的模式和程度,并对酒精使用障碍和重度抑郁症进行研究诊断。通过酒精使用障碍识别测试的得分评估酒精使用障碍的严重程度。分别使用酶联免疫吸附测定法(ELISA)和多重技术测量血清BDNF和细胞因子。虽然血清BDNF水平与重度抑郁症病史无关,但有近期抑郁症状的患者(n = 42)与无近期抑郁症状的患者(n = 110)相比,其血清BDNF水平较低(均值±标准差)(21.6±8.1 ng/mL对26.0±9.6 ng/mL;p = 0.010),并且酒精使用障碍严重程度较高和有暴饮模式的患者与酒精使用障碍严重程度较低和无暴饮的患者相比,其平均血清BDNF水平更高(25.9±9.7 ng/mL对22.1±8.7 ng/mL;p = 0.022以及25.7±9.3对21.8±9.7 ng/mL;p = 0.029)。BDNF与TNF-α(r = 0.39,p < 0.001)和IL-6(r = 0.2,p = 0.027)之间存在正相关。特别是,在控制混杂因素后,TNF-α水平可预测BDNF水平(B = 0.3 [95%置信区间= 0.2 - 0.5],p < 0.001)。这些发现表明,在饮酒人群中,外周BDNF水平与酒精使用障碍的严重程度以及抑郁症状的存在有关。炎症和神经营养因子之间的显著关联可能对酒精使用障碍康复期间的神经适应性变化有影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验